...
首页> 外文期刊>British Journal of Cancer >A novel fragment derived from the |[beta]| chain of human fibrinogen, |[beta]|43|[ndash]|63, is a potent inhibitor of activated endothelial cells in vitro and in vivo
【24h】

A novel fragment derived from the |[beta]| chain of human fibrinogen, |[beta]|43|[ndash]|63, is a potent inhibitor of activated endothelial cells in vitro and in vivo

机译:衍生自|β|的新型片段人纤维蛋白原链|β| 43 | n | 63是体外和体内激活的内皮细胞的有效抑制剂

获取原文

摘要

Background:Angiogenesis and haemostasis are closely linked within tumours with many haemostatic proteins regulating tumour angiogenesis. Indeed we previously identified a fragment of human fibrinogen, fibrinogen E-fragment (FgnE) with potent anti-angiogenic properties in vitro and cytotoxic effects on tumour vessels in vivo. We therefore investigated which region of FgnE was mediating vessel cytotoxicity.
机译:背景:血管生成和止血与许多调节肿瘤血管生成的止血蛋白紧密相关。实际上,我们之前已经鉴定出人纤维蛋白原的片段,即纤维蛋白原E片段(FgnE),在体外具有有效的抗血管生成特性,并且在体内对肿瘤血管具有细胞毒性作用。因此,我们调查了FgnE的哪个区域正在介导血管细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号